⚡️ What’s new in healthcare this week?

GLP-1 pills go mainstream, AI adoption splits consumers and providers, major funding rounds surge, and healthcare gears up for Health 2.0. This month’s biggest shifts in one scroll.

Biorce develops AI-powered simulation technology that helps pharmaceutical companies design and optimize clinical trials before they run. Its platform creates virtual patient cohorts using biological, clinical, and real-world data to predict trial outcomes, refine protocols, and test different scenarios. By identifying risks and improving study design upfront, Biorce aims to reduce trial failures, shorten timelines, and lower development costs.

---

Hey there Insider,

Hope you had a fantastic week!

Here’s your must-read weekly roundup of the latest news and developments in the digital healthcare sector! 👇🏼

1. Top news in Digital Health from March 2026.

2. FDA approves Eli Lilly’s GLP-1 pill for weight loss.

3. The tortoise and the hare of care: Health AI insights from Rock Health’s 2025 Consumer Adoption Survey.

3. Cleveland Clinic pilots EHR-integrated AI for inpatient nursing.

4. Announcing Stedi’s $50 million Series C.

5. eMed Secures $200M Series A at $2B+ Valuation to Scale AI-Powered GLP-1 Employer Platform.

6. WHOOP raises $575M, hits $10.1B valuation.

7. myStoria raises $1.625M to build care coordination platform for reproductive health patients.

8. 2026 Physician Survey on Augmented Intelligence.

9. Changes in clinician time expenditure and visit quantity with adoption of artificial intelligence–powered scribes.

10. Penguin Ai Launches Gwen, a Build-Your-Own AI Platform for Healthcare Operations.

April 7-9th | Las Vegas, NA.
2026 USA Health Summit.

Until next week, stay connected!

Digital Health Insider.